Additionally, we found expression of MYC, 4EBP1, LARP1, and hnRNPC to be significantly increased in primary samples from newly diagnosed multiple myeloma (NDMM) patients compared to plasma cells (PC) from healthy donors (Figure 7C). The gene discussed is MYC; the disease is AL amyloidosis.